{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:48:24Z","timestamp":1789778904382,"version":"4.0.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"vor","delay-in-days":374,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jacc.2015.12.005","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T15:03:11Z","timestamp":1454338991000},"page":"545-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":332,"title":["Testosterone and Cardiovascular Disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Robert A.","family":"Kloner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Culley","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Emile R.","family":"Mohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.12.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-8-1-1","article-title":"Biological actions of androgens","volume":"8","author":"Mooradian","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacc.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tcm.2014.10.014","article-title":"Testosterone therapy and cardiovascular risk","volume":"25","author":"Walsh","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib3","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib4","first-page":"3204","article-title":"Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS)","volume":"8","author":"Khera","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2014-3818","article-title":"Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials","volume":"100","author":"Cunningham","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib6","first-page":"579","article-title":"IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men","volume":"10","author":"Zitzmann","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib7","doi-asserted-by":"crossref","first-page":"E1135","DOI":"10.1152\/ajpendo.90213.2008","article-title":"Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss","volume":"294","author":"Knapp","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/gerona\/glr100","article-title":"Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation","volume":"66","author":"Travison","year":"2011","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2015.12.005_bib9","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40618-013-0009-x","article-title":"Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome","volume":"37","author":"Iglesias","year":"2014","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jacc.2015.12.005_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-444-59602-4.00008-3","article-title":"Hypothalamic-pituitary hormones during critical illness: a dynamic neuroendocrine response","volume":"124","author":"Langouche","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jacc.2015.12.005_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-15-0359","article-title":"Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease","volume":"173","author":"Dhindsa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2015.12.005_bib13","article-title":"Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy","author":"Sumii","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.jacc.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"86","author":"Harman","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2015.12.005_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/hrt.2010.210757","article-title":"Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis","volume":"97","author":"Ruige","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.12.005_bib18","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jcem.87.8.8762","article-title":"Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study","volume":"87","author":"Hak","year":"2002","journal-title":"J\u00a0Clin Endocrin Metal"},{"key":"10.1016\/j.jacc.2015.12.005_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.ijir.3901504","article-title":"Low testosterone levels are associated with coronary artery disease in male patients with angina","volume":"19","author":"Rosano","year":"2007","journal-title":"Int J\u00a0Impot Res"},{"key":"10.1016\/j.jacc.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","article-title":"High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden","volume":"58","author":"Ohlsson","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib21","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.ejim.2011.08.016","article-title":"Low testosterone level in middle-aged male patients with coronary artery disease","volume":"22","author":"Hu","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/aja.2012.95","article-title":"Testosterone is negatively associated with the severity of coronary atherosclerosis in men","volume":"14","author":"Li","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib23","first-page":"545","article-title":"The association between premature coronary artery disease and level of testosterone in young adult males","volume":"17","author":"Alkamel","year":"2014","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1210\/jc.2014-2585","article-title":"Low testosterone concentration and atherosclerosis disease markers in male patients with type 2 diabetes","volume":"99","author":"Farias","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5534\/wjmh.2014.32.3.139","article-title":"Relationship between serum testosterone and cardiovascular disease risk determined using the Framingham Risk Score in male patients with sexual dysfunction","volume":"32","author":"Lee","year":"2014","journal-title":"World J Mens Health"},{"key":"10.1016\/j.jacc.2015.12.005_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MED.0000000000000057","article-title":"Testosterone, aging, and survival: biomarker or deficiency","volume":"21","author":"Shores","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacc.2015.12.005_bib27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1517\/14656566.2014.913022","article-title":"An update on male hypogonadism therapy","volume":"15","author":"Surampudi","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacc.2015.12.005_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/13685538.2015.1052392","article-title":"Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function","volume":"18","author":"Golan","year":"2015","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.12.005_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.2012.11774.x","article-title":"Androgen deprivation therapy: evidence-based management of side effects","volume":"111","author":"Ahmadi","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jacc.2015.12.005_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cpf.12084","article-title":"Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer","volume":"34","author":"Girard","year":"2014","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.jacc.2015.12.005_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/aja.2011.104","article-title":"Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy","volume":"14","author":"Storer","year":"2012","journal-title":"Asian J\u00a0Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jcem-57-3-557","article-title":"The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men","volume":"57","author":"Kwan","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib34","first-page":"688","article-title":"A\u00a0simple self-report diary for assessing psychosexual function in hypogonadal men","volume":"24","author":"Lee","year":"2003","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.urology.2008.10.019","article-title":"Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score","volume":"73","author":"Chiang","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jacc.2015.12.005_bib36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib37","first-page":"1577","article-title":"Testosterone supplementation and sexual function: a meta-analysis study","volume":"11","author":"Corona","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib38","first-page":"3546","article-title":"Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate","volume":"80","author":"Guay","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1472-6823-11-18","article-title":"Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)","volume":"11","author":"Bhattacharya","year":"2011","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jacc.2015.12.005_bib40","first-page":"530","article-title":"Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?","volume":"173","author":"Greenstein","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacc.2015.12.005_bib41","first-page":"658","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","volume":"172","author":"Shabsigh","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacc.2015.12.005_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2003.11.009","article-title":"Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging","volume":"63","author":"Cavallini","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.jacc.2015.12.005_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/jcem.84.2.5495","article-title":"Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study","volume":"84","author":"Barrett-Connor","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib44","first-page":"2572","article-title":"Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome","volume":"7","author":"Giltay","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0891988704271767","article-title":"Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy","volume":"18","author":"Orengo","year":"2005","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jacc.2015.12.005_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/hbeh.1998.1439","article-title":"Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities","volume":"33","author":"Alexander","year":"1998","journal-title":"Horm Behav"},{"key":"10.1016\/j.jacc.2015.12.005_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1162\/089892900562228","article-title":"Sex steroids modify working memory","volume":"12","author":"Janowsky","year":"2000","journal-title":"J\u00a0Cogn Neurosci"},{"key":"10.1016\/j.jacc.2015.12.005_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.12.005_bib49","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/ijcp.12418","article-title":"Experiences and treatment pattern of hypogonadal men in the US health system","volume":"68","author":"Shortridge","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2015.12.005_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/ijcp.12636","article-title":"Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan","volume":"69","author":"Shortridge","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2015.12.005_bib51","first-page":"2670","article-title":"Effects of testosterone replacement in hypogonadal men","volume":"85","author":"Snyder","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib52","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib53","first-page":"2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncpendmet0120","article-title":"Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging","volume":"2","author":"Bhasin","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib55","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2012-3695","article-title":"Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels","volume":"98","author":"Hildreth","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrendo.2013.73","article-title":"Risks and benefits of testosterone therapy in older men","volume":"9","author":"Spitzer","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 5","key":"10.1016\/j.jacc.2015.12.005_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bju.12964","article-title":"Adverse effects of androgen-deprivation therapy in prostate cancer and their management","volume":"115","author":"Rhee","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.jacc.2015.12.005_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13685538.2011.631230","article-title":"Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study","volume":"15","author":"Aversa","year":"2012","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.12.005_bib60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bju.12870","article-title":"The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density","volume":"115","author":"Dabaja","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.jacc.2015.12.005_bib61","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MOU.0000000000000104","article-title":"Bone health in hypogonadal men","volume":"24","author":"Irwig","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.jacc.2015.12.005_bib62","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib63","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2014where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.2004-0970","article-title":"The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study","volume":"90","author":"Laaksonen","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/eje.0.1460505","article-title":"Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study","volume":"146","author":"Rolf","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2015.12.005_bib66","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: a meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1008-682X.122346","article-title":"Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cai","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib68","doi-asserted-by":"crossref","first-page":"e000272","DOI":"10.1161\/JAHA.113.000272","article-title":"Testosterone and the cardiovascular system: a comprehensive review of the clinical literature","volume":"2","author":"Oskui","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2015.12.005_bib69","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2015.12.005_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2015.12.005_bib71","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men: a systemic review and meta-analysis","volume":"95","author":"Fern\u00e1ndez-Balsells","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib72","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.12.005_bib73","first-page":"624","article-title":"Death by testosterone? We think not!","volume":"11","author":"Traish","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib74","first-page":"613","article-title":"Knowledge is power","volume":"11","author":"Goldstein","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/1008-682X.146968","article-title":"Controversies in testosterone replacement therapy: testosterone and cardiovascular disease","volume":"17","author":"Hwang","year":"2015","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrurol.2014.24","article-title":"Testosterone and cardiovascular risk\u2014deciphering the statistics","volume":"11","author":"Morgantaler","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jacc.2015.12.005_bib77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/smrj.36","article-title":"Testosterone and cardiovascular health: safety of treatment of hypogonadism","volume":"3","author":"Kloner","year":"2015","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.jacc.2015.12.005_bib78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/13685538.2014.913413","article-title":"Testosterone and cardiovascular risk: world\u2019s experts take unprecedented action to correct misinformation","volume":"17","author":"Morgantaler","year":"2014","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.12.005_bib79","doi-asserted-by":"crossref","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2015.12.005_bib80","unstructured":"Woodcock J. Letter to Sidney Wolfe, M.D. and Michael Carome, M.D., responding to FDA-2014-P-0258, Public Citizen\u2019s petition for boxed warning for testosterone-containing drugs. Food and Drug Administration. July 16, 2014. Available at: http:\/\/www.citizen.org\/documents\/2184_FDA Denial of Petition_July 16, 2014.pdf. Accessed December 2,\u00a02015."},{"key":"10.1016\/j.jacc.2015.12.005_bib81","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamainternmed.2015.1573","article-title":"Comparative safety of testosterone dosage forms [published erratum appears in JAMA Intern Med 2015;175:1248]","volume":"175","author":"Layton","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib82","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib83","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.61.2.162","article-title":"Increased incidence of diagnosed depressive illness in hypogonadal older men","volume":"61","author":"Shores","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jacc.2015.12.005_bib84","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1060028014539918","article-title":"Risk of myocardial infarction in older men receiving testosterone therapy","volume":"48","author":"Baillargeon","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2015.12.005_bib85","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES 2 Study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2015.12.005_bib86","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2015.12.005_bib87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2008.12.107","article-title":"Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease","volume":"142","author":"Cornoldi","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systemic review and meta-analysis of placebo-controlled randomized trails","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2015.12.005_bib89","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular risk associated with testosterone-boosting medications: a systemic review and meta-analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expert Opinion Drug Saf"},{"key":"10.1016\/j.jacc.2015.12.005_bib90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/2042098614548680","article-title":"Adverse effects of testosterone replacement therapy: an update on the evidence and controversy","volume":"5","author":"Grech","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jacc.2015.12.005_bib91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/1008-682X.148728","article-title":"Controversies in testosterone supplementation therapy","volume":"17","author":"Khera","year":"2015","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jacc.2015.12.005_bib92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","article-title":"Testosterone therapy and cardiovascular risk: advances and controversies","volume":"90","author":"Morgentaler","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2015.12.005_bib93","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.005_bib94","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1740774514524032","article-title":"The Testosterone Trials: seven coordinated trials of testosterone treatment in elderly men","volume":"11","author":"Snyder","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.jacc.2015.12.005_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248410378121","article-title":"Testosterone therapy: treatment of metabolic disturbances in heart failure","volume":"16","author":"Naghi","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2015.12.005_bib96","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.106.649426","article-title":"Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival","volume":"114","author":"Jankowska","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.005_bib97","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2009.05.039","article-title":"Testosterone: a novel therapeutic approach in chronic heart failure?","volume":"54","author":"Aukrust","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/13685538.2014.896893","article-title":"Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China","volume":"17","author":"Chen","year":"2014","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.12.005_bib99","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13685538.2013.768979","article-title":"Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure","volume":"16","author":"Rydlewska","year":"2013","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.12.005_bib100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","article-title":"The decline of\u00a0androgen levels in elderly men and its clinical and therapeutic implications","volume":"26","author":"Kaufman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacc.2015.12.005_bib101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.1979.tb02075.x","article-title":"Pituitary-gonadal dysfunction in low output cardiac failure","volume":"10","author":"Tappler","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2015.12.005_bib102","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cardfail.2008.12.011","article-title":"Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure","volume":"15","author":"Jankowska","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2015.12.005_bib103","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0195-668X(03)00083-6","article-title":"Acute haemodynamic effects of testosterone in men with chronic heart failure","volume":"24","author":"Pugh","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.005_bib104","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2015.12.005_bib105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCHEARTFAILURE.111.965632","article-title":"Testosterone supplementation in heart failure: a meta-analysis","volume":"5","author":"Toma","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2015.12.005_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.005_bib107","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib108","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/hrt.2003.014639","article-title":"Testosterone treatment for men with chronic heart failure","volume":"90","author":"Pugh","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.12.005_bib109","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","article-title":"Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study","volume":"54","author":"Caminiti","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/2047487314533084","article-title":"Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction","volume":"22","author":"Nicolli","year":"2015","journal-title":"Eur J\u00a0Prev Cardiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib111","doi-asserted-by":"crossref","first-page":"H115","DOI":"10.1152\/ajpheart.00046.2011","article-title":"Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase","volume":"302","author":"Deenadayalu","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2015.12.005_bib112","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/hrt.2003.021121","article-title":"Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life","volume":"90","author":"Malkin","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.12.005_bib113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-09-0092","article-title":"Long-term benefits of testosterone replacement therapy on\u00a0angina threshold and atheroma in men","volume":"161","author":"Mathur","year":"2009","journal-title":"Eur J\u00a0Endocrinol"},{"key":"10.1016\/j.jacc.2015.12.005_bib114","doi-asserted-by":"crossref","first-page":"e000271","DOI":"10.1161\/JAHA.113.000271","article-title":"Testosterone and the cardiovascular system: a\u00a0comprehensive review of the basic science literature","volume":"2","author":"Herring","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2015.12.005_bib115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1074248415587977","article-title":"Roles of testosterone replacement in cardiac ischemia-reperfusion injury","volume":"21","author":"Pongkan","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2015.12.005_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6607.1000115","article-title":"Supraphysiological testosterone levels shorten the QT interval but do not alter total anatomic myocardial infarct size in rabbits with acute myocardial infarction","volume":"3","author":"Herring","year":"2014","journal-title":"Cardiol Pharmacol"},{"key":"10.1016\/j.jacc.2015.12.005_bib117","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1076029613499819","article-title":"Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study","volume":"20","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2015.12.005_bib118","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.mayocp.2015.05.012","article-title":"Risk of venous thromboembolism in men receiving testosterone therapy","volume":"90","author":"Baillargeon","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2015.12.005_bib119","unstructured":"Bhatt K, Johnson J. Summary Minutes of the Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting, September 18, 2014. U.S. Food and Drug\u00a0Administration, Center for Drug Evaluation and Research. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/ReproductiveHealthDrugsAdvisoryCommittee\/UCM424069.pdf. Accessed December 2, 2015."},{"key":"10.1016\/j.jacc.2015.12.005_bib120","unstructured":"FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. U.S. Food and\u00a0Drug Administration. 2015. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm436259.htm. Accessed December 2,\u00a02015."},{"key":"10.1016\/j.jacc.2015.12.005_bib121","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/jcem-70-1-282","article-title":"Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production","volume":"70","author":"Matsumoto","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715077591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715077591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T19:05:26Z","timestamp":1654196726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715077591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0735109715077591"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.005","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone and Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}